These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11451349)

  • 21. Risk adjustment and outcome research. Part I.
    Arcà M; Fusco D; Barone AP; Perucci CA
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):682-90. PubMed ID: 16932082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When to use relative risk or odds ratios in describing study results.
    Mayer DM; Young A
    Ann Emerg Med; 2005 Oct; 46(4):385-6; author reply 386. PubMed ID: 16183401
    [No Abstract]   [Full Text] [Related]  

  • 23. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
    J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistics review 11: assessing risk.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Aug; 8(4):287-91. PubMed ID: 15312212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation measures in epidemiology].
    Ollivier L; Michel R; Spiegel A; Boutin JP
    Med Trop (Mars); 2003; 63(1):75-8. PubMed ID: 12891755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Razón de posibilidades: a proposed translation of the term odds ratio].
    Tapia JA; Nieto FJ
    Salud Publica Mex; 1993; 35(4):419-24. PubMed ID: 8342087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse childhood experiences and sexual risk behaviors in women: a retrospective cohort study.
    Hillis SD; Anda RF; Felitti VJ; Marchbanks PA
    Fam Plann Perspect; 2001; 33(5):206-11. PubMed ID: 11589541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding relative risk, odds ratio, and related terms: as simple as it can get.
    Andrade C
    J Clin Psychiatry; 2015 Jul; 76(7):e857-61. PubMed ID: 26231012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does low participation in cohort studies induce bias?
    Nohr EA; Frydenberg M; Henriksen TB; Olsen J
    Epidemiology; 2006 Jul; 17(4):413-8. PubMed ID: 16755269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primer: Demystifying risk--understanding and communicating medical risks.
    Crowson CS; Therneau TM; Matteson EL; Gabriel SE
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):181-7; quiz 1 p following 187. PubMed ID: 17334341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of parity with mortality outcomes among triplets.
    Salihu HM; Aliyu MH; Rouse DJ; Kirby RS; Alexander GR
    Am J Obstet Gynecol; 2004 Mar; 190(3):784-9. PubMed ID: 15042015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
    Siqueira AL; Whitehead A; Todd S
    Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative-risk ratio was a useful measure of differential association in cohort and case-series studies.
    Hocine MN; Tubert-Bitter P; Moreau T; Chavance M; Varon E; Guillemot D
    J Clin Epidemiol; 2007 Apr; 60(4):361-5. PubMed ID: 17346610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Using "number needed to treat" to interpret treatment effect].
    Ke DS
    Acta Neurol Taiwan; 2006 Jun; 15(2):120-6. PubMed ID: 16871900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members.
    Pascoe L; Zouali H; Sahbatou M; Hugot JP
    Eur J Hum Genet; 2007 Aug; 15(8):864-71. PubMed ID: 17457368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Statistical notes. Absolute and relative effect measures].
    Marubini E; Reina G
    Ital Heart J Suppl; 2004 Jun; 5(6):466-71. PubMed ID: 15471151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
    Srivastava DK; Rai SN; Pan J
    Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression.
    Larsen K; Merlo J
    Am J Epidemiol; 2005 Jan; 161(1):81-8. PubMed ID: 15615918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.